Zebra Technologies Corporation
ZBRA News Today: Stay Updated with the Latest Zebra Technologies Corporation News in Real Time
Find ZBRA news now at Meyka AI. Stay informed with the latest Zebra Technologies Corporation stocks updates, including price news, market analysis, and expert insights.

Pre-market volume spike 24 Feb 2026: 3738.T T-Gaia (JPX) JPY 2,659 watch flows
Pre-market volume spike for 3738.T stock on 24 Feb 2026 at JPY 2,659; volume 157,000 vs avg 1,243. Quick analysis and price targets.

OCX OncoCyte NASDAQ After Hours 23 Feb 2026: $3.20 oversold bounce, watch $3.80
OCX stock rises to $3.20 after hours on 23 Feb 2026 after an oversold bounce; analysis, price targets and risks for NASDAQ-listed OncoCyte

BTIG Maintains Neutral on OPEN Opendoor Technologies Inc. Feb 23 2026
BTIG kept a Neutral OPEN analyst rating on Feb 23, 2026; implications, context, and Meyka analysis of Opendoor

CICN.SW down to CHF 163.00 on 23 Feb 2026: AI demand supports outlook
CICN.SW stock at CHF 163.00 on 23 Feb 2026 β valuation, Meyka AI grade, and a CHF 209.58 yearly forecast

6619.T W-SCOPE (JPX) EPS -189.78 JPY on 24 Feb 2026: pre-market earnings watch
Pre-market earnings spotlight on 6619.T stock: W-SCOPE posts EPS -189.78 JPY; Meyka AI projects monthly 179.64 JPY

A$0.555 AIM.AX AiβMedia (ASX) pre-market 24 Feb 2026: earnings due 26 Feb, AI demand in focus
Pre-market AIM.AX stock at A$0.555; earnings 26 Feb 2026 and Meyka AI forecast A$0.8918

IFX.DE Infineon closes β¬45.84 on XETRA 23 Feb 2026: AI demand reshapes outlook
IFX.DE stock close β¬45.84 on XETRA; AI demand, valuation and Meyka AI forecast examined

HCLTECH.NS HCL Technologies (NSE) closed INR 1450.40 on 23 Feb 2026: AI stock outlook
HCLTECH.NS stock closed at INR 1450.40 on 23 Feb 2026. We analyse AI growth, valuation and a INR 1,950.15 yearly forecast for investors.

Pre-market: A31.SI Addvalue Technologies Ltd rises to S$0.091 on heavy volume: what traders should watch
A31.SI stock pre-market update: price S$0.091, volume 70.32M, Meyka AI forecast S$0.101, outlook and risks